Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 3/20 | 0.66 |
| ▸ | TLR2 | O60603 | 1/20 | 0.66 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.66 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.66 |
| ▸ | SRC | P12931 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29954368 | 1.00 | ERN1 (0.66) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL19911767 | 0.91 | ERN1 (0.56) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL6468006 | 0.87 | ERN1 (0.55) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL13140330 | 0.84 | ERN1 (0.49) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL30203585 | 0.83 | ERN1 (0.66) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL851964 | 0.83 | ALDH1A1 (0.52) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL29953692 | 0.83 | ALDH1A1 (0.52) | ERN1TLR2TLR1TLR6SRC | |
| 2-Methoxybenzaldehyde SCHEMBL8469378 | 0.82 | ALDH1A1 (0.66) | ERN1TLR2TLR1TLR6SRC | |
| SCHEMBL31689790 | 0.82 | NFE2L2 (0.55) | ERN1TLR2TLR1TLR6CYP1A2 | |
| SCHEMBL31689795 | 0.82 | NFE2L2 (0.55) | ERN1TLR2TLR1TLR6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4624447-A1 | METHODS OF MAKING AND USING 1-METHYLEFFUSOL | Laboratory for Synthetic Chemistry and Chemical Biology Limited (HK) | 2025-10-01 | — | — | EP | claimed |
| CN-118955434-A | Modified multi-functionality epoxy resin and preparation method and application thereof | 韦尔通科技股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118956309-A | Underfill adhesive, and preparation method and application thereof | 韦尔通科技股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-115335378-A | Monoacylglycerol lipase modulators | 詹森药业有限公司 | 2022-11-11 | — | — | CN | claimed |
| EP-3131539-B1 | SEMICARBAZIDE-SENSITIVE AMINE OXIDASE INHIBITORS FOR USE AS ANALGESICS IN TRAUMATIC NEUROPATHY AND NEUROGENIC INFLAMMATION | PECSI TUDOMANYEGYETEM (HU) | 2018-12-05 | — | — | EP | claimed |
| EP-0639559-B1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM & HAAS (US) | 1997-10-15 | — | — | EP | claimed |
| EP-4624447-A1 | METHODS OF MAKING AND USING 1-METHYLEFFUSOL | Laboratory for Synthetic Chemistry and Chemical Biology Limited (HK) | 2025-10-01 | — | — | EP | disclosed |
| US-20250115577-A1 | BCL-2 Inhibitors | Eil Therapeutics, Inc. | 2025-04-10 | — | — | US | disclosed |
| CN-115335378-B | Monoacylglycerol lipase modulators | 詹森药业有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-118955434-A | Modified multi-functionality epoxy resin and preparation method and application thereof | 韦尔通科技股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118956309-A | Underfill adhesive, and preparation method and application thereof | 韦尔通科技股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| EP-4457223-A1 | BCL-2 INHIBITORS | Eil Therapeutics, Inc. (US) | 2024-11-06 | — | — | EP | disclosed |
| CN-118451070-A | BCL-2 inhibitors | 伊尔治疗学股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| EP-0639559-A1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM AND HAAS COMPANY (US) | 1995-02-22 | — | — | EP | disclosed |
| US-5225584-A | Phosphonate esters and trialkylsilyl phosphonate esters | TROPIX, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0441948-A4 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | — | 1992-06-03 | — | — | EP | disclosed |
| EP-0441948-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| WO-1991003479-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-03-21 | — | — | WO | disclosed |
| US-4444567-A | ALKOXY BENZALDEHYDES, ALKOXY BENZOATES | PHILLIPS PETROLEUM COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4058642-A | HYPERTENSIVE | BOEHRINGER INGELHEIM GMBH (DT) | 1977-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115577-A1 | BCL-2 Inhibitors | BCL2, BCL2L1, BCL2L2 | ERN1 1457/4885TLR2 3820/4885TLR1 4564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.